We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SE:NYSESea Limited Analysis

Data as of 2026-08-01 - not real-time

$106.74

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sea Limited (SE) is delivering robust top‑line growth, with Q1 revenue up 46.6% YoY to $25.2 bn and a healthy gross margin of 44.3%, while maintaining a positive profit margin of 6.4% and generating $0.89 bn of free cash flow. The balance sheet is solid, featuring $10.5 bn of cash against $3.6 bn of debt (debt‑to‑equity 27.6%). However, valuation remains stretched: the stock trades at a forward PE of ~20x versus a DCF‑derived fair value of $61.9, implying a price premium of roughly 70% over intrinsic estimates. Technicals are mixed – the price sits above the 20‑day (106.3) and 50‑day (96.7) SMAs but below the 200‑day SMA (110.6), RSI is neutral at 57, while MACD shows a bearish histogram and volume is on a downtrend. Analyst sentiment is very positive, with a “strong buy” consensus, a median target of $138 and an implied upside of ~33%, and the market sentiment index is in “Extreme Greed” territory.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and decreasing volume suggest limited near‑term upside
  • Current price is near resistance at $115.7 with limited upside on the chart
  • Valuation remains above intrinsic estimates despite strong earnings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained double‑digit revenue growth and expanding digital payments franchise
  • Analyst consensus “strong buy” with median target $138 indicating ~30% upside
  • Strong cash position and improving free cash flow support continued investment

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑run secular tailwinds in Southeast Asian e‑commerce and gaming markets
  • Diversified platform (Shopee, Garena, digital financial services) creates network effects
  • Management’s track record of scaling operations and capital efficiency

Key Metrics & Analysis

Financial Health

Revenue Growth46.60%
Profit Margin6.36%
P/E Ratio42.0
ROE14.86%
ROA4.87%
Debt/Equity27.61
P/B Ratio5.1
Op. Cash Flow$5.3B
Free Cash Flow$885.2M

Technical Analysis

TrendNeutral
RSI57.1
Support$97.59
Resistance$115.72
MA 20$106.29
MA 50$96.69
MA 200$110.62
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Fair Value$61.91
Target Price$142.26
Upside/Downside33.27%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.45
Volatility42.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.